Skip to main content
. Author manuscript; available in PMC: 2023 May 31.
Published in final edited form as: Laryngoscope. 2020 Dec 2;131(7):1663–1669. doi: 10.1002/lary.29290

TABLE IV.

Outcomes in Therapy Non-responders, n = 11 (12-month Post-operative AHI ≥5).

Characteristic Baseline (SD) 12-Month (SD) Change (SD) P Value

Parent-reported outcomes
 OSA-18
  Survey score 3.5 (1.1) 1.8 (0.9) −1.7 (1.4) .002
  Total score 70.7 (13.4) 31.5 (9.5) −38.5 (20.1) .005
 Domain average scores
  Sleep disorders 4.6 (1.4) 2.1 (0.9) −2.5 (1.4) .0003
  Physical distress 2.1 (0.9) 1.9 (0.8) −0.2 (0.8) .46
  Emotional distress 3.2 (1.8) 1.8 (1.0) −1.2 (1.9) .07
  Diurnal problems 3.6 (1.1) 2.3 (1.0) −1.3 (1.4) .02
  Caretaker 4.2 (1.7) 1.6 (0.8) −2.6 (2.0) .003
   Preoccupation
  Overall quality of Life* 4.1 (1.8) 7.7 (1.6) +3.5 (1.7) .0001
  Epworth sleepiness score mean score 7.6 (5.4) 5.0 (5.2) −2.1 (3.3) .07
Polysomnographic outcomes
 Respiratory events
  AHI 22.1 (9.2) 13.8 (16.0) −8.2 (12.4) .05
  Obstructive AHI 19.9 (8.9) 12.4 (15.2) −7.5 (12.1) .07
  Central apnea index 2.2 (1.5) 1.5 (1.5) −0.65 (2.1) .32
  Hypopnea proportion 70.7% (25.3%) 80.9% (15.0%) 10.2% (28.9%) .27
  Supine AHI 23.4 (15.5) 17.8 (18.6) −5.6 (14.1) .22
 Oxygenation
  Percentage of time 5.5% (12.2%) 0.84% (2.8%) −4.7% (12.8%) .11
   SpO2 < 90%
  SpO2 Nadir 85.2% (6.1%) 87.6% (5.2%) +2.4% (5.3%) .05
  Baseline SpO2 96.4% (1.5%) 95.0% (1.5%) −1.3% (1.5%) .01
 Sleep fragmentation
  Sleep efficiency 67.3% (16.2%) 69.2% (19.9%) +1.9% (23.7%) .80
  Stage N1 percentage 7.8% (8.7%) 4.6% (5.0%) −3.2% (7.4%) .07
  REM percentage 13.6% (8.0%) 12.6% (0.1%) −1.0% (10.3%) .75

AHI = apnea-hypopnea index; SD = standard deviation; REM = rapid eye movement; SpO2 = oxygen saturation.

*

Scored on a scale of 0 to 10 where higher scores correspond to better quality of life.